Neuro65/AOCN2024

Session information

Oral Session

English

[O-29] Oral Session 29 [English]「Motor neuron disease 1」

Fri. May 31, 2024 8:00 AM - 9:30 AM Room6 (Hall D7, D Block, 7F, TIF)

Chair(s): Hirofumi Maruyama (Hiroshima University, Japan), Ryoichi Nakamura (Department of Neurology, Aichi Medical University, Japan)

Eiichiro Nagata1, Masatoshi Ito2, Natsuko Fujii1, Saori Kohara1, Masayuki Tanaka3, Masaki Takao4, Ban Mihara5, Yuko Saito6, Akiyoshi Kakita7 (1.Department of Neurology, Tokai University School of Medicine, Japan, 2.Department of Legal Medicine, St. Marianna University School of Medicine, Japan, 3.Support Center for Medical Research and Education, Tokai University, Japan, 4.Department of Clinical Laboratory, National Center of Neurology and Psychiatry, National Center Hospital, Japan, 5.Department of Neurology, Mihara Memorial Hospital, Japan, 6.Department of Neuropathology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Japan, 7.Department of Pathology, Brain Research Institute, Niigata University, Japan)

Kodai Kume1, Takashi Kurashige1,4, Keiko Muguruma2, Hiroyuki Morino3, Mai Kikumoto1,4, Masahiro Nakamori4, Ayumi Nishiyama5, Rumiko Koizumi5, Masashi Ogasawara6, Nobuyuki Eura6, Yoshiaki Nakayama7, Hidefumi Ito7, Masataka Nakayama8, Yuichi Riku9, Yasushi Iwasaki9, Hirofumi Maruyama4, Ichizo Nishino6, Yuishin Izumi10, Masashi Aoki5, Hideshi Kawakami1 (1.Department of Molecular Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan, 2.Department of iPS Cell Applied Medicine, Graduate School of Medicine, Kansai Medical University, Japan, 3.Department of Medical Genetics, Tokushima University Graduate School of Biomedical Sciences, Japan, 4.Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan, 5.Department of Neurology, Tohoku University Graduate School of Medicine, Japan, 6.Department of Neuromuscular Research, National Institute of Neuroscience, National Centre of Neurology and Psychiatry, Japan, 7.Department of Neurology, Wakayama Medical University, Japan, 8.Department of Neurology, Kansai Medical University, Japan, 9.Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Japan, 10.Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan)

Tetsuhiro Ueda1,3,4, Toshihide Takeuchi2,3, Nobuhiro Fujikake5, Toshiki Mizuno4, Yoshitaka Nagai1,2,3,5 (1.Department of Neurology, Kindai University Faculty of Medicine, Japan, 2.Life Science Research Institute, Kindai University, Japan, 3.Departments of Neurotherapeutics, Osaka University Graduate School of Medicine, Japan, 4.Department of Neurology, Kyoto Prefectural University of Medicine, Japan, 5.Departments of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan)

Akiyuki Ohno1, Naoki Suzuki1, Yuichi Shichino2, Noriyoshi Isozumi3, Saki Saitoh1, Ryuhei Harada1, Naoko Nakamura1, Shio Mitsuzawa1, Tomomi Shijo1, Kensuke Ikeda1, Hitoshi Warita1, Eiichiro Mori3, Shintaro Iwasaki2, Masashi Aoki1 (1.Department of Neurology, Tohoku University Graduate School of Medicine, Japan, 2.RNA Systems Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Japan, 3.Department of Future Basic Medicine, Nara Medical University, Japan)